PURVIN JEFFREY L 4
4 · RESPONSE BIOMEDICAL CORP · Filed Aug 16, 2012
Insider Transaction Report
Form 4
PURVIN JEFFREY L
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2012-08-15+6,000,000→ 6,000,000 totalExercise: $0.08Exp: 2022-08-15→ Common Stock (6,000,000 underlying)
Footnotes (2)
- [F1]Exercise prices shown are denominated in Canadian dollars.
- [F2](i) 25% of such Options shall vest and become exercisable on the date which is one year after the date of grant; (ii) an additional 1/48th of the Options initially granted to such Optionee will vest and be exercisable on the first day of each calendar month beginning on the first calendar month after the calendar month in which the Options described in the immediately preceding paragraph (b)(i) vest and continuing for 35 additional consecutive calendar months until all such Options contemplated hereby are vested and fully exercisable; and (iii) expire on the date that is 10 years from the date of grant.